New Indications for Ultrasound in the Staging of Cervical Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00451945
First received: March 23, 2007
Last updated: June 17, 2008
Last verified: June 2008
  Purpose

The purpose is to investigate and evaluate two new diagnostic methods using ultrasound in the staging of cervical cancer.

  1. 3-D-ultrasound of the tumour to estimate its volume and local spread
  2. Fusion of PET/CT and ultrasound to evaluate and biopsy lymph nodes.

Condition Intervention
Cervical Cancer
Procedure: biopsy
Device: 3d-ultrasound and fusion of UL and PET/CT

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
Official Title: New Indications for Ultrasound in the Staging of Cervical Cancer

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Study Start Date: March 2007
Estimated Study Completion Date: March 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • Cervical cancer,
  • PET/CT pos. lymph nodes,
  • Patients over 18 years old

Exclusion Criteria:

  • Pregnancy,
  • Lactating,
  • Diabetic
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00451945

Locations
Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
Investigators
Principal Investigator: Michael B Nielsen, MDSc Department of radiology, section of ultrasound
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00451945     History of Changes
Other Study ID Numbers: H-KF 2007-004
Study First Received: March 23, 2007
Last Updated: June 17, 2008
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on September 16, 2014